| Detected | Trial | Change |
|---|---|---|
| 2026-08-15 | NCT06870812 Rapid Evacuation and Access of Cerebral Hemorrhage Trial |
Trial sites expanded: 21 -> 24 locations |
| 2026-08-13 | NCT07185399 Systems Biological Analysis of Immune Responses to RSV Vaccine |
date change Primary completion pushed: 2026-07 -> 2027-01 |
| 2026-08-13 | NCT07185399 Systems Biological Analysis of Immune Responses to RSV Vaccine |
date change Completion pushed: 2026-07 -> 2027-01 |
| 2026-08-09 | NCT03942224 Daratumumab, Ixazomib, & Dexamethasone or Daratumumab, Bortezomib, & Dexamethasone in… |
overall status: Active, Not Recruiting → Unknown |
| 2026-08-08 | NCT06932588 Biomarker Role in Assessing Imaging Needs for Mild Cranial Trauma |
Enrollment closed, study ongoing |
| 2026-08-08 | NCT06932588 Biomarker Role in Assessing Imaging Needs for Mild Cranial Trauma |
date change Primary completion pushed: 2026-06 -> 2026-07-09 |
| 2026-08-08 | NCT06932588 Biomarker Role in Assessing Imaging Needs for Mild Cranial Trauma |
date change Completion pushed: 2026-06 -> 2027-07 |
| 2026-08-08 | NCT03762759 Fluciclovine F18 or Ga68-PSMA PET/CT to Enhance Prostate Cancer Outcomes |
Primary endpoint(s) modified |
| 2026-08-08 | NCT03762759 Fluciclovine F18 or Ga68-PSMA PET/CT to Enhance Prostate Cancer Outcomes |
date change Completion pushed: 2025-12-31 -> 2030-05-19 |
| 2026-08-08 | NCT06865820 Implementation and Cost Evaluation of Project UPLIFT |
date change Primary completion pushed: 2026-12-15 -> 2027-08 |
| 2026-08-08 | NCT06865820 Implementation and Cost Evaluation of Project UPLIFT |
date change Completion pushed: 2026-12-15 -> 2027-08 |
| 2026-08-06 | NCT06254911 Pre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related… |
Recruitment resumed after suspension |
| 2026-08-05 | NCT05384847 Effects of Triiodothyronine (T3) in Ischemic Heart Failure |
Trial completed |
| 2026-08-05 | NCT05384847 Effects of Triiodothyronine (T3) in Ischemic Heart Failure |
Phase changed: Phase 1/2 -> Phase 1 |
| 2026-08-05 | NCT05384847 Effects of Triiodothyronine (T3) in Ischemic Heart Failure |
Enrollment reduced: 20 -> 14 participants |
| 2026-08-05 | NCT05384847 Effects of Triiodothyronine (T3) in Ischemic Heart Failure |
Trial arms changed: 4 -> 3 |
| 2026-08-05 | NCT05384847 Effects of Triiodothyronine (T3) in Ischemic Heart Failure |
date change Primary completion moved earlier: 2026-05 -> 2025-10-01 |
| 2026-08-05 | NCT05384847 Effects of Triiodothyronine (T3) in Ischemic Heart Failure |
date change Completion moved earlier: 2026-05 -> 2025-10-01 |
| 2026-08-05 | NCT06295458 Gamma Sensory Flicker for Parkinson's Disease Patients With Freezing of Gait |
Trial completed |
| 2026-08-05 | NCT06295458 Gamma Sensory Flicker for Parkinson's Disease Patients With Freezing of Gait |
date change Completion moved earlier: 2027-06 -> 2026-05-04 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-14 | NCT07764796 Mobile Health Patient Navigation for the Improvement of Screening and the Early Detection… | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05616546 | Bone Marrow and Peripheral Blood Immune Responses Study | Influenza | Recruiting |
| NCT06799494 | HPV Vaccine Reduced Dose | HPV | Recruiting |
| NCT05292339 | Ketorolac in Upper Extremity Tendinopathy and Arthropathy | Osteoarthritis | Recruiting |
| NCT04641702 | Comprehensive Esophageal Diagnostics Study | Achalasia | Recruiting |
| NCT07197762 | MenB-FHbp or MenACWY-TT/MenB-FHbp Vaccine in MenB-4C Primed Young Adults | Neisseria Meningitidis | Recruiting |
| NCT06075771 | Dopaminergic Therapy for Anhedonia - 2 | Anhedonia | Recruiting |
| NCT06979492 | Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease | Sickle Cell Disease | Recruiting |
| NCT06234995 | Cortical Electrophysiology of Response Inhibition in Parkinson's Disease | Parkinson Disease | Recruiting |
| NCT05537935 | Low Dose Naltrexone for Pain in Patients With HIV | Human Immunodeficiency Virus | Recruiting |
| NCT07215325 | Got Doxy- 'Flipping the Script' on STI PEP | Sexually Transmitted Infections (STI) | Recruiting |
| NCT05823532 | Anti-Inflammatory Challenge in Schizophrenia | Schizophrenia | Recruiting |
| NCT06699810 | Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity | Ketosis Prone Diabetes | Recruiting |
| NCT07226739 | Comprehensive Toileting Program | Encopresis | Recruiting |
| NCT05801978 | Durability of Vaccine Responses | Vaccine Response | Recruiting |
| NCT07101445 | Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the… | Multiple Myeloma | Recruiting |
| NCT05031078 | Assessing Durable Antibody Response to HPV Vaccination | HPV | Active, Not Recruiting |
| NCT04416269 | Oral Anti Diabetic Agents in the Hospital | Diabetes Mellitus | Active, Not Recruiting |
| NCT03661645 | Post-operative Methylprednisolone Taper Course for Orthopedic Surgery | Orthopedic Surgeries | Enrolling by Invitation |
| NCT07624526 | Role of Suzetrigine as a Part of a Multimodal Regimen to Reduce Pain and Opioid Use After… | Knee Arthritis | Not Yet Recruiting |
| NCT07185399 | Systems Biological Analysis of Immune Responses to RSV Vaccine | Respiratory Syncytial Virus (RSV) | Active, Not Recruiting |
| Phase 3 | |||
| NCT07212114 | Efficacy of EXPAREL vs. Bupivacaine | Total Ankle Arthroplasty | Recruiting |
| NCT06650579 | REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial | Recurrent Prostate Carcinoma | Recruiting |
| NCT05834478 | Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3 | Withdrawal Symptoms | Recruiting |
| NCT07348627 | Opioid-Sparing Joint Replacement | Pain Management | Recruiting |
| NCT04563520 | SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis | Hemophilia A | Recruiting |